Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)

Clinical trial NCT06045793 · TERMINATED

Trial details

NCT number: NCT06045793
Sponsor: Tonix Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cocaine Use Cocaine Intoxication Cocaine Toxicity Cocaine Abuse Cocaine Adverse Reaction

Start date: 2024-08-16
Primary completion: 2025-04-21
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.